Community Acquired Pneumonia Market
1 Introduction to Research & Analysis Reports
1.1 Community Acquired Pneumonia (CAP) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Community Acquired Pneumonia (CAP) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Community Acquired Pneumonia (CAP) Overall Market Size
2.1 Global Community Acquired Pneumonia (CAP) Market Size: 2021 VS 2028
2.2 Global Community Acquired Pneumonia (CAP) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Community Acquired Pneumonia (CAP) Players in Global Market
3.2 Top Global Community Acquired Pneumonia (CAP) Companies Ranked by Revenue
3.3 Global Community Acquired Pneumonia (CAP) Revenue by Companies
3.4 Top 3 and Top 5 Community Acquired Pneumonia (CAP) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Community Acquired Pneumonia (CAP) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Community Acquired Pneumonia (CAP) Players in Global Market
3.6.1 List of Global Tier 1 Community Acquired Pneumonia (CAP) Companies
3.6.2 List of Global Tier 2 and Tier 3 Community Acquired Pneumonia (CAP) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Community Acquired Pneumonia (CAP) Market Size Markets, 2021 & 2028
4.1.2 Chest X-ray/Radiography
4.1.3 Sputum Gram Stain and/or Culture
4.1.4 Blood Cultures
4.2 By Type - Global Community Acquired Pneumonia (CAP) Revenue & Forecasts
4.2.1 By Type - Global Community Acquired Pneumonia (CAP) Revenue, 2017-2022
4.2.2 By Type - Global Community Acquired Pneumonia (CAP) Revenue, 2023-2028
4.2.3 By Type - Global Community Acquired Pneumonia (CAP) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Community Acquired Pneumonia (CAP) Market Size, 2021 & 2028
5.1.2 Hospitals and Clinics
5.1.3 Others
5.2 By Application - Global Community Acquired Pneumonia (CAP) Revenue & Forecasts
5.2.1 By Application - Global Community Acquired Pneumonia (CAP) Revenue, 2017-2022
5.2.2 By Application - Global Community Acquired Pneumonia (CAP) Revenue, 2023-2028
5.2.3 By Application - Global Community Acquired Pneumonia (CAP) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Community Acquired Pneumonia (CAP) Market Size, 2021 & 2028
6.2 By Region - Global Community Acquired Pneumonia (CAP) Revenue & Forecasts
6.2.1 By Region - Global Community Acquired Pneumonia (CAP) Revenue, 2017-2022
6.2.2 By Region - Global Community Acquired Pneumonia (CAP) Revenue, 2023-2028
6.2.3 By Region - Global Community Acquired Pneumonia (CAP) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Community Acquired Pneumonia (CAP) Revenue, 2017-2028
6.3.2 US Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.3.3 Canada Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.3.4 Mexico Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Community Acquired Pneumonia (CAP) Revenue, 2017-2028
6.4.2 Germany Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.4.3 France Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.4.4 U.K. Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.4.5 Italy Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.4.6 Russia Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.4.7 Nordic Countries Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.4.8 Benelux Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Community Acquired Pneumonia (CAP) Revenue, 2017-2028
6.5.2 China Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.5.3 Japan Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.5.4 South Korea Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.5.5 Southeast Asia Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.5.6 India Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Community Acquired Pneumonia (CAP) Revenue, 2017-2028
6.6.2 Brazil Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.6.3 Argentina Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Community Acquired Pneumonia (CAP) Revenue, 2017-2028
6.7.2 Turkey Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.7.3 Israel Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.7.4 Saudi Arabia Community Acquired Pneumonia (CAP) Market Size, 2017-2028
6.7.5 UAE Community Acquired Pneumonia (CAP) Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Community Acquired Pneumonia (CAP) Major Product Offerings
7.1.4 Pfizer Community Acquired Pneumonia (CAP) Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Astrazeneca
7.2.1 Astrazeneca Corporate Summary
7.2.2 Astrazeneca Business Overview
7.2.3 Astrazeneca Community Acquired Pneumonia (CAP) Major Product Offerings
7.2.4 Astrazeneca Community Acquired Pneumonia (CAP) Revenue in Global Market (2017-2022)
7.2.5 Astrazeneca Key News
7.3 Bioaegis Therapeutics
7.3.1 Bioaegis Therapeutics Corporate Summary
7.3.2 Bioaegis Therapeutics Business Overview
7.3.3 Bioaegis Therapeutics Community Acquired Pneumonia (CAP) Major Product Offerings
7.3.4 Bioaegis Therapeutics Community Acquired Pneumonia (CAP) Revenue in Global Market (2017-2022)
7.3.5 Bioaegis Therapeutics Key News
7.4 Biotest
7.4.1 Biotest Corporate Summary
7.4.2 Biotest Business Overview
7.4.3 Biotest Community Acquired Pneumonia (CAP) Major Product Offerings
7.4.4 Biotest Community Acquired Pneumonia (CAP) Revenue in Global Market (2017-2022)
7.4.5 Biotest Key News
7.5 C10 Pharma
7.5.1 C10 Pharma Corporate Summary
7.5.2 C10 Pharma Business Overview
7.5.3 C10 Pharma Community Acquired Pneumonia (CAP) Major Product Offerings
7.5.4 C10 Pharma Community Acquired Pneumonia (CAP) Revenue in Global Market (2017-2022)
7.5.5 C10 Pharma Key News
7.6 Kyorin Pharmaceutical
7.6.1 Kyorin Pharmaceutical Corporate Summary
7.6.2 Kyorin Pharmaceutical Business Overview
7.6.3 Kyorin Pharmaceutical Community Acquired Pneumonia (CAP) Major Product Offerings
7.6.4 Kyorin Pharmaceutical Community Acquired Pneumonia (CAP) Revenue in Global Market (2017-2022)
7.6.5 Kyorin Pharmaceutical Key News
7.7 Melinta Therapeutics
7.7.1 Melinta Therapeutics Corporate Summary
7.7.2 Melinta Therapeutics Business Overview
7.7.3 Melinta Therapeutics Community Acquired Pneumonia (CAP) Major Product Offerings
7.7.4 Melinta Therapeutics Community Acquired Pneumonia (CAP) Revenue in Global Market (2017-2022)
7.7.5 Melinta Therapeutics Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Community Acquired Pneumonia (CAP) Major Product Offerings
7.8.4 Merck Community Acquired Pneumonia (CAP) Revenue in Global Market (2017-2022)
7.8.5 Merck Key News
7.9 Nabriva Therapeutics
7.9.1 Nabriva Therapeutics Corporate Summary
7.9.2 Nabriva Therapeutics Business Overview
7.9.3 Nabriva Therapeutics Community Acquired Pneumonia (CAP) Major Product Offerings
7.9.4 Nabriva Therapeutics Community Acquired Pneumonia (CAP) Revenue in Global Market (2017-2022)
7.9.5 Nabriva Therapeutics Key News
7.10 Paratek Pharmaceuticals
7.10.1 Paratek Pharmaceuticals Corporate Summary
7.10.2 Paratek Pharmaceuticals Business Overview
7.10.3 Paratek Pharmaceuticals Community Acquired Pneumonia (CAP) Major Product Offerings
7.10.4 Paratek Pharmaceuticals Community Acquired Pneumonia (CAP) Revenue in Global Market (2017-2022)
7.10.5 Paratek Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Community Acquired Pneumonia (CAP) Market Opportunities & Trends in Global Market
Table 2. Community Acquired Pneumonia (CAP) Market Drivers in Global Market
Table 3. Community Acquired Pneumonia (CAP) Market Restraints in Global Market
Table 4. Key Players of Community Acquired Pneumonia (CAP) in Global Market
Table 5. Top Community Acquired Pneumonia (CAP) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Community Acquired Pneumonia (CAP) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Community Acquired Pneumonia (CAP) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Community Acquired Pneumonia (CAP) Product Type
Table 9. List of Global Tier 1 Community Acquired Pneumonia (CAP) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Community Acquired Pneumonia (CAP) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Community Acquired Pneumonia (CAP) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Community Acquired Pneumonia (CAP) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Community Acquired Pneumonia (CAP) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Community Acquired Pneumonia (CAP) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Community Acquired Pneumonia (CAP) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Community Acquired Pneumonia (CAP) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Community Acquired Pneumonia (CAP) Product Offerings
Table 32. Pfizer Community Acquired Pneumonia (CAP) Revenue (US$, Mn), (2017-2022)
Table 33. Astrazeneca Corporate Summary
Table 34. Astrazeneca Community Acquired Pneumonia (CAP) Product Offerings
Table 35. Astrazeneca Community Acquired Pneumonia (CAP) Revenue (US$, Mn), (2017-2022)
Table 36. Bioaegis Therapeutics Corporate Summary
Table 37. Bioaegis Therapeutics Community Acquired Pneumonia (CAP) Product Offerings
Table 38. Bioaegis Therapeutics Community Acquired Pneumonia (CAP) Revenue (US$, Mn), (2017-2022)
Table 39. Biotest Corporate Summary
Table 40. Biotest Community Acquired Pneumonia (CAP) Product Offerings
Table 41. Biotest Community Acquired Pneumonia (CAP) Revenue (US$, Mn), (2017-2022)
Table 42. C10 Pharma Corporate Summary
Table 43. C10 Pharma Community Acquired Pneumonia (CAP) Product Offerings
Table 44. C10 Pharma Community Acquired Pneumonia (CAP) Revenue (US$, Mn), (2017-2022)
Table 45. Kyorin Pharmaceutical Corporate Summary
Table 46. Kyorin Pharmaceutical Community Acquired Pneumonia (CAP) Product Offerings
Table 47. Kyorin Pharmaceutical Community Acquired Pneumonia (CAP) Revenue (US$, Mn), (2017-2022)
Table 48. Melinta Therapeutics Corporate Summary
Table 49. Melinta Therapeutics Community Acquired Pneumonia (CAP) Product Offerings
Table 50. Melinta Therapeutics Community Acquired Pneumonia (CAP) Revenue (US$, Mn), (2017-2022)
Table 51. Merck Corporate Summary
Table 52. Merck Community Acquired Pneumonia (CAP) Product Offerings
Table 53. Merck Community Acquired Pneumonia (CAP) Revenue (US$, Mn), (2017-2022)
Table 54. Nabriva Therapeutics Corporate Summary
Table 55. Nabriva Therapeutics Community Acquired Pneumonia (CAP) Product Offerings
Table 56. Nabriva Therapeutics Community Acquired Pneumonia (CAP) Revenue (US$, Mn), (2017-2022)
Table 57. Paratek Pharmaceuticals Corporate Summary
Table 58. Paratek Pharmaceuticals Community Acquired Pneumonia (CAP) Product Offerings
Table 59. Paratek Pharmaceuticals Community Acquired Pneumonia (CAP) Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Community Acquired Pneumonia (CAP) Segment by Type in 2021
Figure 2. Community Acquired Pneumonia (CAP) Segment by Application in 2021
Figure 3. Global Community Acquired Pneumonia (CAP) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Community Acquired Pneumonia (CAP) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Community Acquired Pneumonia (CAP) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Community Acquired Pneumonia (CAP) Revenue in 2021
Figure 8. By Type - Global Community Acquired Pneumonia (CAP) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Community Acquired Pneumonia (CAP) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Community Acquired Pneumonia (CAP) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Community Acquired Pneumonia (CAP) Revenue Market Share, 2017-2028
Figure 12. US Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Community Acquired Pneumonia (CAP) Revenue Market Share, 2017-2028
Figure 16. Germany Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 17. France Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Community Acquired Pneumonia (CAP) Revenue Market Share, 2017-2028
Figure 24. China Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 28. India Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Community Acquired Pneumonia (CAP) Revenue Market Share, 2017-2028
Figure 30. Brazil Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Community Acquired Pneumonia (CAP) Revenue Market Share, 2017-2028
Figure 33. Turkey Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Community Acquired Pneumonia (CAP) Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Community Acquired Pneumonia (CAP) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Astrazeneca Community Acquired Pneumonia (CAP) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bioaegis Therapeutics Community Acquired Pneumonia (CAP) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biotest Community Acquired Pneumonia (CAP) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. C10 Pharma Community Acquired Pneumonia (CAP) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Kyorin Pharmaceutical Community Acquired Pneumonia (CAP) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Melinta Therapeutics Community Acquired Pneumonia (CAP) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck Community Acquired Pneumonia (CAP) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Nabriva Therapeutics Community Acquired Pneumonia (CAP) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Paratek Pharmaceuticals Community Acquired Pneumonia (CAP) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
